What's breaking now, across thousands of outlets.
VectorY Therapeutics added €74.5 million ($83.5 million) to its Series A to fund a gene therapy that makes antibodies in the brain. The biotech’s lead asset VTx-002 is in a
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
If you’ve spent any Sunday this fall watching an NFL broadcast, you may have noticed a shift in the advertising landscape.
A surprising study of more than 4,500 older adults found that people who were overweight or obese when diagnosed with dementia had a 16% to 27% lower risk of death than those at a normal weight.
A surprising study of more than 4,500 older adults found that people who were overweight or obese when diagnosed with dementia had a 16% to 27% lower risk of death than those at a normal weight.
Pooling data from 66 brain imaging studies, researchers found that autistic individuals showed differences in white matter microstructure across many of the brain’s major pathways, particularly…
Country is in the middle of worst measles outbreak since 1991, with more than 5,400 cases nationally The United States could lose its measles elimination status this week, an event likely to cement…
Country is in the middle of worst measles outbreak since 1991, with more than 5,400 cases nationally The United States could lose its measles elimination status this week, an event likely to cement…
